A Study of a Bivalent Influenza Peptide Conjugate Vaccine in Healthy Adults
Clinical trial NCT00851266 · COMPLETED
Trial details
- NCT number
- NCT00851266
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Primary completion
- 2007-08-01
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.